Yair Herishanu
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 16
- Internal Medicine top 10%
- Hematology top 5%
- Immunology top 10%
- Immunodeficiency and Autoimmune Disorders 3
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 9
-
- Cancer Immunotherapy and Biomarkers 5
- COVID-19 and healthcare impacts 3
- CAR-T cell therapy research 3
-
- Advanced Breast Cancer Therapies 2
-
- Heparin-Induced Thrombocytopenia and Thrombosis 2
- Co-authors
- Aaron PolliackOri RogowskiChava PerryLudmila ShopinOri ElkayamDaphna ParanRonen Ben‐AmiAdrian Wiestner
- Cited by
- GeneticsInternal MedicineHematology
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of the American Chemical Society (1 paper)Journal of Clinical Oncology (4 papers)
- Partner nations
- IsraelUnited StatesCanada
In The Last Decade
Yair Herishanu
35 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 85
- Genetics 207
- Internal Medicine 60
- Hematology 175
- Immunology 279
- Pathology and Forensic Medicine 213
Countries citing papers authored by Yair Herishanu
This map shows the geographic impact of Yair Herishanu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yair Herishanu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yair Herishanu more than expected).
Fields of papers citing papers by Yair Herishanu
This network shows the impact of papers produced by Yair Herishanu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yair Herishanu. The network helps show where Yair Herishanu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yair Herishanu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 1 | |
| 5 | 2022 | 18 | |
| 6 | 2021 | 1 | |
| 7 | 2021 | 6 | |
| 8 | 2021 | 1 | |
| 9 | 2018 | 8 | |
| 10 | 2017 | 72 | |
| 11 | 2016 | 107 | |
| 12 | 2016 | 26 | |
| 13 | 2012 | 21 | |
| 14 | 2012 | 16 | |
| 15 | 2011 | 93 | |
| 16 | 2007 | 92 | |
| 17 | 2006 | 125 | |
| 18 | 2005 | 96 | |
| 19 | 2004 | 49 | |
| 20 | 2001 | 8 |
About Yair Herishanu
Yair Herishanu is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine, having authored 36 papers that have together received 1.0k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (16 papers), Lymphoma Diagnosis and Treatment (9 papers), Cancer Immunotherapy and Biomarkers (5 papers), COVID-19 and healthcare impacts (3 papers), CAR-T cell therapy research (3 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Advanced Breast Cancer Therapies (2 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (2 papers). The work is most often cited by research in Genetics (207 citations), Internal Medicine (60 citations) and Hematology (175 citations). Yair Herishanu has collaborated with scholars based in Israel, United States and Canada. Frequent co-authors include Aaron Polliack, Ori Rogowski, Chava Perry, Ludmila Shopin, Ori Elkayam, Daphna Paran, Ronen Ben‐Ami, Adrian Wiestner, Osnat Bairey and Lev Shvidel. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.